Mallinckrodt offloads BioVectra for $250 million

The company has agreed to sell its contract manufacturing unit to alleviate some of its debt woes as it faces a myriad of opioid lawsuits
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news